Loading...
Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-Intensity Conditioning with Fludarabine and Melphalan
Reduced-intensity conditioning has extended the use of allogeneic hematopoietic stem cell transplantation (HSCT) to patients otherwise not eligible for this treatment due to older age or frailty. One hundred twelve acute myelogenous leukemia/myelodysplastic syndromes patients received fludarabine an...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4080636/ https://ncbi.nlm.nih.gov/pubmed/17382251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2006.11.024 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|